IPO registrations (S-1, F-1) · Registrants
Nexalin Technology, Inc.
- SEC CIK
- 1527352 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2022-01-04, last 2026-10-08; 4 initial registrations, 15 amendments
- Outcome
- Final prospectus filed 2022-09-19; declared effective 2022-09-15; withdrawal requested 2024-05-14
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Incorporated in
- DE
- Business address
- 1776 YORKTOWN, SUITE 550, Houston, TX 77056
- EIN
- 27-5566468
- Ticker
- NXL (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Nexalin Technology, Inc. on the corporate pages
Offering terms
- Proposed price range
- $6.00–$7.00 per share (S-1/A filed 2022-09-15)
- Final price
- $4.15 per share, below the range (424B4 filed 2022-09-19, an initial public offering)
- Shares sold
- 2,315,000
- Gross proceeds
- $9,607,250 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NXL
- Lead underwriters
- Maxim Group
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: NEXALIN TECHNOLOGY, INC. Fuzzy (name and state)
- Lobbying client: NEXALIN TECHNOLOGY INC. Fuzzy (name and state)
- SEC filer: Nexalin Technology, Inc. EXACT (CIK (EXACT))
Filings 29
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2022-01-04 | S-1 | S-1 (registration) | Nexalin Technology, Inc. | 0001174947-22-000015 ↗ |
| 2022-01-31 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0000891092-22-000235 ↗ |
| 2022-02-04 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0000891092-22-000351 ↗ |
| 2022-04-08 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-22-007966 ↗ |
| 2022-04-28 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-22-008910 ↗ |
| 2022-05-16 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-22-011103 ↗ |
| 2022-05-31 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-22-012325 ↗ |
| 2022-08-24 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-22-016146 ↗ |
| 2022-09-15 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-22-016882 ↗ |
| 2022-09-15 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-22-016885 ↗ |
| 2022-09-15 | EFFECT | EFFECT (declared effective) | Nexalin Technology, Inc. | 9999999995-22-002714 ↗ |
| 2022-09-19 | 424B4 | 424B4 (final prospectus) | Nexalin Technology, Inc. | 0001829126-22-016957 ↗ |
| 2024-05-14 | RW | RW (withdrawal request) | Nexalin Technology, Inc. | 0001829126-24-003342 ↗ |
| 2024-05-23 | S-1 | S-1 (registration) | Nexalin Technology, Inc. | 0001829126-24-003705 ↗ |
| 2024-06-14 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-24-004207 ↗ |
| 2024-06-24 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-24-004393 ↗ |
| 2024-06-26 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-24-004428 ↗ |
| 2024-06-27 | EFFECT | EFFECT (declared effective) | Nexalin Technology, Inc. | 9999999995-24-001990 ↗ |
| 2024-07-01 | 424B4 | 424B4 (final prospectus) | Nexalin Technology, Inc. | 0001829126-24-004494 ↗ |
| 2024-12-20 | S-1 | S-1 (registration) | Nexalin Technology, Inc. | 0001829126-24-008446 ↗ |
| 2025-01-10 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-25-000158 ↗ |
| 2025-01-30 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-25-000571 ↗ |
| 2025-02-03 | EFFECT | EFFECT (declared effective) | Nexalin Technology, Inc. | 9999999995-25-000284 ↗ |
| 2025-04-29 | EFFECT | EFFECT (declared effective) | Nexalin Technology, Inc. | 9999999995-25-001291 ↗ |
| 2025-05-02 | 424B4 | 424B4 (final prospectus) | Nexalin Technology, Inc. | 0001829126-25-003319 ↗ |
| 2025-05-06 | 424B4 | 424B4 (final prospectus) | Nexalin Technology, Inc. | 0001829126-25-003425 ↗ |
| 2026-09-03 | S-1 | S-1 (registration) | Nexalin Technology, Inc. | 0001829126-26-009723 ↗ |
| 2026-10-08 | S-1/A | S-1/A (amendment) | Nexalin Technology, Inc. | 0001829126-26-010913 ↗ |
| 2026-10-15 | EFFECT | EFFECT (declared effective) | Nexalin Technology, Inc. | 9999999995-26-003253 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-09-15 | S-1/A | registration statement | $6.00–$7.00 | $6.00 | 1,500,000 | $9,000,000 | Nasdaq NXL | 1 | primary document; range, price sentence, shares headline, proceeds table | document ↗ |
| 2022-09-19 | 424B4 | final prospectus | $4.15 | 2,315,000 | $9,607,250 | Nasdaq NXL | 1 | primary document; price sentence, shares headline, proceeds table | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Elson Marilyn | Officer,TenPercentOwner; Other; TenPercentOwner | Ms. Elson serves as CFO | 10 | 2022–2025 | |
| Hu Ben | Director | 5 | 2022–2025 | ||
| Kazden Alan | Director | 7 | 2022–2025 | ||
| Morad Rick | Director | 4 | 2022–2023 | ||
| OSSER LEONARD | Other; TenPercentOwner; TenPercentOwner,Other | 10 | 2022–2025 | ||
| Owens David | Director,Officer | Chief Medical Officer | 17 | 2022–2025 | |
| White Mark | Director,Officer | CEO; President and CEO; President/CEO | 7 | 2022–2025 | |
| Bernhard Leslie | Director | 1 | 2024 | ||
| Shelton Carolyn Hamby | Officer | Senior VP; Sr. VP - Quality - Regulatory; Sr. VP - Quality, Regulatory | 4 | 2025 | |
| Van Fleet Justin | Officer | CFO | 2 | 2025 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | NEXALIN TECHNOLOGY, INC. | TX | State business registries | name and state |
| Lobbying client | NEXALIN TECHNOLOGY INC. | TX | Federal lobbying (LDA) | name and state |
| Patent assignee | NEXALIN TECHNOLOGY, INC. | TX | Patents (USPTO) | name and state |
| SEC filer | Nexalin Technology, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | NEXALIN TECHNOLOGY, INC. | TX | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, TX first:
- ARTHROCARE CORP TX
- Integer Holdings Corp TX
- CYBERONICS INC TX
- ENDOCARE INC CA
- NOVT CORP GA
- IMAGYN MEDICAL INC CA
- CARDIAC PATHWAYS CORP CA
- SABRATEK CORP IL
- ARADIGM CORP CA
- SURVIVALINK CORP MN
In other datasets, the same topic (Technology) in TX:
- Lobbying client: 3001 INC (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology